United States Vaccines Market Overview
Base Year: 2023
Historical Years: 2018-2023
Forecast Years: 2024-2032
Market Growth Rate: 5.91% (2024-2032)
Growth in the U.S. vaccine industry is steady. Strong healthcare infrastructure and ongoing innovation support this progress. Increased awareness and related government initiatives propel further market development. According to the latest report by IMARC Group, the United States vaccines market size is projected to exhibit a growth rate (CAGR) of 5.91% during 2024-2032.
Download a sample copy of the Report: https://www.imarcgroup.com/united-states-vaccines-market/requestsample
United States Vaccines Industry Trends and Drivers:
The United States vaccine market is growing fast. This growth comes from new biotech advances, more awareness of preventive healthcare, and the ongoing effects of COVID-19. The pandemic showed how important vaccines are for public health. It led to more investment in research and development (RD) for new vaccines. This was especially true for mRNA technologies. Pfizer, Moderna, and Johnson Johnson have broadened their portfolios. They focus on COVID-19 and other infectious diseases, such as influenza, RSV, and HPV. The CDC and FDA are key players in speeding up approvals and ensuring safety. This helps boost confidence in the market. Personalized medicine and AI in vaccine development are transforming the industry. These advances allow for faster and more targeted solutions. Public-private partnerships are thriving. Government programs, such as BARDA, support new and creative projects. Challenges remain, such as vaccine hesitancy, supply chain issues, and high production costs. Stakeholders must tackle these to keep growth going.
A major trend in the United States vaccines market is the rising demand for adult and senior immunization. This demand comes from an aging population and more chronic diseases. The market has traditionally focused on vaccines for kids. Now, it is shifting to vaccines for adults. These include shingles, pneumococcal vaccines, and booster doses for tetanus and pertussis. This change is backed by good reimbursement policies from Medicare and private insurance. So, vaccines are now easier for older adults to access. The travel vaccines market is growing. International tourism is increasing after the pandemic. Many places now need proof of vaccination for diseases such as yellow fever and typhoid. CVS and Walgreens are taking advantage of this trend. They offer easy vaccination services, which helps grow the market. The FDA offers priority review vouchers and fast-track designations. These incentives help companies make vaccines for neglected tropical diseases and new pathogens. Even with these positive changes, access to vaccines is still unequal.
Our report provides a deep dive into the market analysis, outlining the current trends, underlying United States vaccines market demand, and growth trajectories.
United States Vaccines Industry Segmentation:
The report has segmented the market into the following categories:
Technology Insights:
- Conjugate Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Others
Patient Type Insights:
- Pediatric
- Adult
Indication Insights:
- Bacterial Diseases
- Meningococcal Disease
- Pneumococcal Disease
- Diphtheria/Tetanus/Pertussis (DPT)
- Tuberculosis
- Haemophilus Influenzae (Hib)
- Typhoid
- Others
- Viral Diseases
- Hepatitis
- Influenza
- Human Papillomavirus (HPV)
- Measles/Mumps/Rubella (MMR)
- Rotavirus
- Herpes Zoster
- Varicella
- Japanese Encephalitis
- Rubella
- Polio
- Rabies
- Dengue
- Others
Route of Administration Insights:
- Intramuscular and Subcutaneous Administration
- Oral Administration
- Others
Product Type Insights:
- Multivalent Vaccine
- Monovalent Vaccine
Treatment Type Insights:
- Preventive Vaccine
- Therapeutic Vaccine
End User Insights:
- Hospitals
- Clinics
- Vaccination Centers
- Academic and Research Institutes
- Others
Distribution Channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Institutional Sales
- Others
Regional Insights:
- Northeast
- Midwest
- South
- West
Competitive Landscape:
The competitive landscape of the industry has also been examined, along with the profiles of the key players.
Key highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Historical, Current, and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Structure of the Market
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
